Across TCGA pan-cancer cohorts, STK19 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated STK19 data layer compared with 22 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher STK19 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated STK19 expression acts as an unfavorable survival marker.

COAD and SARC are the cancer types where STK19 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	IV	0.045	0.659	<.001	12	view →
SARC	DFS	Median	All	0.121	0.611	.041	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: STK19 tumor-vs-normal RNA expression · all STK19 data types